<DOC>
	<DOCNO>NCT00470600</DOCNO>
	<brief_summary>The primary objective study Caldolor ( IV ibuprofen ) administer post-operative hospitalized adult orthopedic patient every 6 hour least 24 hour determine efficacy Caldolor ( IV ibuprofen ) compare placebo treatment post-operative pain patient self-assessment pain .</brief_summary>
	<brief_title>Efficacy Safety Study Caldolor ( IV Ibuprofen ) Hospitalized Adult Orthopedic Patients</brief_title>
	<detailed_description />
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Scheduled elective hip knee replacement , reconstruction arthroplasty surgery anticipate need postoperative intravenous ( IV ) morphine analgesia anticipate use ( great equal ( ≥ ) 28 hour . 2 . Adequate IV access 3 . Anticipated hospital stay ≥ 28 hour 1 . Be unable make reliable selfreport pain intensity pain relief 2 . Less 18 year age 3 . Greater 80 year age 4 . Use analgesic , muscle relaxant , NSAIDS sedatives less 12 hour prior clinicaltrial material ( CTM ) administration follow exception : paracetamol ( acetaminophen ) administer 6 hour prior surgery ; tramadol administer midnight even prior surgery ; muscle relaxant work neuromuscular junction use intubation and/or anesthesia administration surgical procedure prior CTM administration ; sedative ( i.e. , midazolam ) use coinduction agent surgical procedure prior CTM administration 5 . Patients take warfarin , lithium , combination angiotension convert enzyme ( ACE ) inhibitor furosemide 6 . Patients anemia ( active , clinically significant anemia ) and/or history evidence asthma heart failure 7 . History allergy hypersensitivity component Caldolor , aspirin ( aspirin relate product ) , NSAIDs , COX2 inhibitors 8 . Pregnant nursing 9 . History severe head trauma require current hospitalization , intracranial surgery stroke within previous 30 day , history intracerebral arteriovenous malformation , cerebral aneurysm CNS mass lesion 10 . Weigh le 30 kilogram 11 . Have history congenital bleeding diathesis ( e.g . hemophilia ) active clinically significant bleeding , underlie platelet dysfunction include ( limited ) idiopathic thrombocytopenic purpura , disseminate intravascular coagulation , congenital platelet dysfunction 12 . Have gastrointestional ( GI ) bleeding require medical intervention within previous 6 week ( unless definitive surgery perform ) 13 . Have platelet count le 30,000 mm^3 determine within 28 day prior surgery 14 . Preexisting dependence narcotic know tolerance opioids 15 . Inability understand requirement study , willing provide write informed consent ( evidenced signature inform consent document approve Institutional Review Board [ IRB ] ) , agree abide study restriction return require assessment 16 . Refusal provide write authorization use disclosure protect health information 17 . Be dialysis , oliguria creatinine great 3.0 milligram/deciliter . 18 . Inability achieve hemostasis inability close surgical incision , prior Operating Room discharge 19 . Operative procedure include organ transplant 20 . Pre intraoperative procedure utilized prevention pre postoperative pain ( i.e . epidural nerve block ) 21 . Be receive full dose anticoagulation therapy Activated Protein C within 6 hour dose ( Prophylaxis subcutaneous heparin acceptable ) 22 . Have receive another investigational drug within past 30 day 23 . Be otherwise unsuitable study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>